Dinaciclib is a potent CDK inhibitor. It affects Rb signaling by reducing Rb phosphorylation, stopping growth, inducing apoptosis.
Dinaciclib (SCH 727965) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Dinaciclib (SCH 727965) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Dinaciclib (SCH 727965) Mechanism of Action: CDK9 Inhibition in Leukemic Cell Research
- Dinaciclib (SCH 727965) Clinical Trials
- Dinaciclib (SCH 727965): Selectivity & Specificity
- Dinaciclib (SCH 727965) Working Concentration | Cell Culture | Treatment
- Dinaciclib (SCH 727965) Solubility in DMSO
- Dinaciclib (SCH 727965) Stock Solution
- Dinaciclib (SCH 727965) Storage
- Dinaciclib (SCH 727965) Stability
- Dinaciclib (SCH 727965) Combination Database
- Dinaciclib (SCH 727965) Molecular Weight
- Dinaciclib (SCH 727965) SMILES
- Dinaciclib (SCH 727965) CAS Number
- Dinaciclib (SCH 727965) Chemical Structure (2D and 3D)
- Dinaciclib (SCH 727965) Sigma (SML3722)? Try a better option.
- Dinaciclib (SCH 727965) MedChemExpress (HY-10492)? Try a better option.
- Dinaciclib (SCH 727965) Cayman (14707)? Try a better option.
- Dinaciclib (SCH 727965) APExBIO (A8412)? Try a better option.
- Dinaciclib (SCH 727965) SDS｜MSDS